HN2012001160A - Agonistas mglu2 - Google Patents

Agonistas mglu2

Info

Publication number
HN2012001160A
HN2012001160A HN2012001160A HN2012001160A HN2012001160A HN 2012001160 A HN2012001160 A HN 2012001160A HN 2012001160 A HN2012001160 A HN 2012001160A HN 2012001160 A HN2012001160 A HN 2012001160A HN 2012001160 A HN2012001160 A HN 2012001160A
Authority
HN
Honduras
Prior art keywords
mglu2
mglu2 agonists
agonists
aguists
schizophrenia
Prior art date
Application number
HN2012001160A
Other languages
English (en)
Inventor
Monn James Allen
Taboada Martinez Lorena
Shaw Bruce William
Prieto Lourdes
Montero Salgado Carlos
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2012001160(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HN2012001160A publication Critical patent/HN2012001160A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION PROVEE AGONISTAS DE MGLU2 NOVEDOSOS UTILES EN EL TRATAMIENTO TRASTORNO BIPOLAR, ESQUIZOFRENIA, DEPRESION, Y TRASTORNO DE ANSIEDAD GENERALIZADA.
HN2012001160A 2009-12-21 2012-05-30 Agonistas mglu2 HN2012001160A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09382290 2009-12-21
US30523910P 2010-02-17 2010-02-17

Publications (1)

Publication Number Publication Date
HN2012001160A true HN2012001160A (es) 2015-08-24

Family

ID=42026702

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2012001160A HN2012001160A (es) 2009-12-21 2012-05-30 Agonistas mglu2

Country Status (35)

Country Link
US (1) US8318184B2 (es)
EP (1) EP2516406B1 (es)
JP (1) JP5779190B2 (es)
KR (1) KR101395356B1 (es)
CN (1) CN102695701B (es)
AR (1) AR079343A1 (es)
AU (1) AU2010340039B2 (es)
BR (1) BR112012017188B1 (es)
CA (1) CA2784667C (es)
CR (1) CR20120322A (es)
CY (1) CY1114880T1 (es)
DK (1) DK2516406T3 (es)
DO (1) DOP2012000173A (es)
EA (1) EA020229B1 (es)
EC (1) ECSP12011989A (es)
ES (1) ES2435651T3 (es)
HK (1) HK1171228A1 (es)
HN (1) HN2012001160A (es)
HR (1) HRP20131052T1 (es)
IL (1) IL220011A (es)
JO (1) JO2978B1 (es)
MA (1) MA33824B1 (es)
MX (1) MX2012007332A (es)
MY (1) MY160618A (es)
NZ (1) NZ600305A (es)
PE (1) PE20121688A1 (es)
PL (1) PL2516406T3 (es)
PT (1) PT2516406E (es)
RS (1) RS53063B (es)
SG (1) SG181836A1 (es)
SI (1) SI2516406T1 (es)
TN (1) TN2012000281A1 (es)
TW (1) TWI477490B (es)
UA (1) UA107684C2 (es)
WO (1) WO2011084437A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG183304A1 (en) 2010-02-17 2012-09-27 Takeda Pharmaceutical Heterocyclic compound
TWI520935B (zh) * 2010-11-18 2016-02-11 美國禮來大藥廠 作為ｍＧｌｕＲ２／３拮抗劑之４－經取代－３－苯基磺醯基甲基－雙環［３.１.０］己烷化合物
BR112013012384A2 (pt) * 2010-11-18 2019-09-24 Lilly Co Eli compostos 3-benzilóóxi-biciclo[3.1.0]hexano 4-substituídos como antagonistas receptores de mglu2 e mglu3
EA023553B1 (ru) * 2011-06-17 2016-06-30 Эли Лилли Энд Компани Агонисты рецептора mglu2
AR089718A1 (es) * 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
HUE053734T2 (hu) 2014-01-21 2021-07-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk
EA201891617A3 (ru) * 2014-01-21 2019-04-30 Янссен Фармацевтика Нв Комбинации, содержащие положительные аллостерические модуляторы или ортостерические агонисты метаботропного глутаматергического рецептора 2 подтипа, и их применение
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576323A (en) * 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5688826A (en) * 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
ZA983930B (en) 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
WO2002055485A1 (en) * 2001-01-11 2002-07-18 Eli Lilly And Company Prodrugs of excitatory amino acids
HUP0400620A3 (en) * 2001-01-11 2012-09-28 Lilly Co Eli Prodrugs of excitatory amino acids and pharmaceutical compositions containing them and process for preparation the compounds
WO2002068380A1 (en) * 2001-02-22 2002-09-06 Eli Lilly And Company Synthetic excitatory amino acids
BR0311558A (pt) * 2002-06-11 2007-04-27 Lilly Co Eli composto ou sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, métodos para afetar os receptores de glutamato metabotrópicos ligados a camp, para administrar uma quantidade eficaz de um composto e para tratar um distúrbio neurológico e psiquiátrico em um paciente, e, formulação farmacêutica
US7381746B2 (en) * 2003-06-26 2008-06-03 Taisho Pharmaceutical Co., Ltd. 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative
TWI520935B (zh) * 2010-11-18 2016-02-11 美國禮來大藥廠 作為ｍＧｌｕＲ２／３拮抗劑之４－經取代－３－苯基磺醯基甲基－雙環［３.１.０］己烷化合物
BR112013012384A2 (pt) * 2010-11-18 2019-09-24 Lilly Co Eli compostos 3-benzilóóxi-biciclo[3.1.0]hexano 4-substituídos como antagonistas receptores de mglu2 e mglu3

Also Published As

Publication number Publication date
PE20121688A1 (es) 2012-12-05
EP2516406B1 (en) 2013-09-18
BR112012017188B1 (pt) 2021-06-22
KR20120094056A (ko) 2012-08-23
JP2013514974A (ja) 2013-05-02
SI2516406T1 (sl) 2013-11-29
PL2516406T3 (pl) 2014-03-31
DOP2012000173A (es) 2012-11-30
HK1171228A1 (en) 2013-03-22
AU2010340039B2 (en) 2014-03-20
PT2516406E (pt) 2013-10-10
IL220011A (en) 2014-03-31
JO2978B1 (en) 2016-03-15
TN2012000281A1 (en) 2013-12-12
CR20120322A (es) 2012-07-10
MX2012007332A (es) 2012-07-20
AR079343A1 (es) 2012-01-18
SG181836A1 (en) 2012-08-30
US8318184B2 (en) 2012-11-27
BR112012017188A2 (pt) 2016-03-22
HRP20131052T1 (hr) 2013-12-06
TWI477490B (zh) 2015-03-21
DK2516406T3 (da) 2013-10-14
TW201144290A (en) 2011-12-16
JP5779190B2 (ja) 2015-09-16
MY160618A (en) 2017-03-15
EA201290558A1 (ru) 2012-12-28
CN102695701A (zh) 2012-09-26
ES2435651T3 (es) 2013-12-20
CA2784667C (en) 2014-11-18
CY1114880T1 (el) 2016-12-14
IL220011A0 (en) 2012-07-31
CA2784667A1 (en) 2011-07-14
AU2010340039A1 (en) 2012-08-09
RS53063B (en) 2014-04-30
WO2011084437A1 (en) 2011-07-14
CN102695701B (zh) 2014-10-01
EP2516406A1 (en) 2012-10-31
ECSP12011989A (es) 2012-07-31
KR101395356B1 (ko) 2014-05-14
US20110152334A1 (en) 2011-06-23
NZ600305A (en) 2014-01-31
UA107684C2 (xx) 2015-02-10
EA020229B1 (ru) 2014-09-30
BR112012017188A8 (pt) 2016-10-04
MA33824B1 (fr) 2012-12-03

Similar Documents

Publication Publication Date Title
HN2012001160A (es) Agonistas mglu2
UA107822C2 (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
ECSP11011541A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
CR11202S (es) Botella
UY33504A (es) N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida deuterada, sales y usos de la misma
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
CR20120362A (es) Ciertas triazolopiridinas y triazolopirazinas, composiciones de estas y sus métodos de empleo
ECSP11011021A (es) Antagonistas de la via hedgehog de ftalazina disustituida
CL2009001363S1 (es) Pieza para maquina de afeitar.
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
HN2010001614A (es) Confitura
CR20110550S (es) Botella
HN2011002059A (es) Tinturas azoicas fibrorreactivas , su preparacion y su uso
CL2008001837A1 (es) Uso de compuestos derivados de cinolin-3-carboxamida en el tratamiento de la esquizofrenia.
HN2009003469A (es) Biscocho lleno
EA201391700A1 (ru) АГОНИСТЫ РЕЦЕПТОРА mGlu2
CL2011002880S1 (es) Rodamiento de bola
CL2009001553S1 (es) Mesa.
CL2009001552S1 (es) Mesa.
CL2009000055S1 (es) Frasco para cosmeticos.
CL2009000054S1 (es) Frasco para cosmeticos.
CR20110546S (es) Es diseno ornamental de la botella tal y como se muestra y describe en la presente solicitud.